Predictions
MacroGenics Inc.
Start price
Target price
Perf. (%)
€12.17
13.01.22
13.01.22
-
13.01.23
13.01.23
-7.52%
22.01.22
22.01.22
Could be worthwhile Investment >10% per year
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€16.62
14.01.22
14.01.22
-
14.01.23
14.01.23
-12.67%
22.01.22
22.01.22
Could be worthwhile Investment >10% per year
Axsome Therapeutics Inc
Start price
Target price
Perf. (%)
€24.44
14.01.22
14.01.22
-
14.01.23
14.01.23
-10.19%
22.01.22
22.01.22
Risky Investment
Dare Bioscience Inc.
Start price
Target price
Perf. (%)
€2.50
21.01.21
21.01.21
€10.00
21.01.22
21.01.22
-47.52%
22.01.22
22.01.22
Could be very worthwhile Investment >20% year
Lipocine Inc.
Start price
Target price
Perf. (%)
€32.30
21.01.21
21.01.21
€136.00
21.01.22
21.01.22
-57.58%
22.01.22
22.01.22
Could be very worthwhile Investment >20% year
Magenta Therapeutics
Start price
Target price
Perf. (%)
€4.08
08.01.22
08.01.22
€6.00
08.01.23
08.01.23
-26.40%
22.01.22
22.01.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Zoetis Inc. A
Start price
Target price
Perf. (%)
€130.34
27.02.21
27.02.21
-
27.02.22
27.02.22
37.81%
20.01.22
20.01.22
Innovative
Medium risks for its business
Top 10 in its market
Future proof or reliable business model
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€55.31
19.01.21
19.01.21
€67.00
19.01.22
19.01.22
14.53%
20.01.22
20.01.22
Top 10 in its market
Good rating
Medium risks for its business
Bad culture
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€55.31
19.01.21
19.01.21
€67.00
19.01.22
19.01.22
14.53%
20.01.22
20.01.22
Top 10 in its market
Good rating
Medium risks for its business
Bad culture
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€55.31
19.01.21
19.01.21
€67.00
19.01.22
19.01.22
14.53%
20.01.22
20.01.22
Top 10 in its market
Good rating
Medium risks for its business
Bad culture
Pfizer Inc.
Start price
Target price
Perf. (%)
€41.11
09.11.21
09.11.21
€60.00
09.11.22
09.11.22
14.73%
19.01.22
19.01.22
Small challenges to pay loans and raise capital
Innovative
Very small cyclical dependencies
Some uniques
Pfizer Inc.
Start price
Target price
Perf. (%)
€41.11
09.11.21
09.11.21
€60.00
09.11.22
09.11.22
14.73%
19.01.22
19.01.22
Small challenges to pay loans and raise capital
Innovative
Very small cyclical dependencies
Some uniques
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€173.98
25.01.21
25.01.21
€250.00
25.01.22
25.01.22
23.00%
17.01.22
17.01.22
Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
DBV Technologies S.A.
Start price
Target price
Perf. (%)
€8.16
15.01.21
15.01.21
-
15.01.22
15.01.22
-63.58%
16.01.22
16.01.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Biogen Inc.
Start price
Target price
Perf. (%)
€194.22
12.01.22
12.01.22
€240.00
12.01.23
12.01.23
-0.90%
12.01.22
12.01.22
Could be worthwhile Investment >10% per year
Known brand
Biogen Inc.
Start price
Target price
Perf. (%)
€194.22
12.01.22
12.01.22
€240.00
12.01.23
12.01.23
-0.90%
12.01.22
12.01.22
Could be worthwhile Investment >10% per year
Known brand
Biogen Inc.
Start price
Target price
Perf. (%)
€194.22
12.01.22
12.01.22
€240.00
12.01.23
12.01.23
-0.90%
12.01.22
12.01.22
Could be worthwhile Investment >10% per year
Known brand
Jazz Pharmaceuticals plc
Start price
Target price
Perf. (%)
€130.15
12.01.22
12.01.22
-
12.01.23
12.01.23
0.00%
12.01.22
12.01.22
Novavax Inc.
Start price
Target price
Perf. (%)
€183.96
17.12.21
17.12.21
€240.00
17.12.22
17.12.22
-37.46%
10.01.22
10.01.22
Could be worthwhile Investment >10% per year
Some uniques
Genocea Biosciences Inc.
Start price
Target price
Perf. (%)
€1.15
27.12.21
27.12.21
-
27.12.22
27.12.22
-18.26%
10.01.22
10.01.22
Could be worthwhile Investment >10% per year
Riot Blockchain Inc.
Start price
Target price
Perf. (%)
€18.94
05.01.22
05.01.22
-
05.01.23
05.01.23
-7.08%
09.01.22
09.01.22
Risky Investment
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€143.65
27.12.21
27.12.21
-
27.12.22
27.12.22
-9.78%
09.01.22
09.01.22
Risky Investment